Evidence map›Paper›PMID 40649698›Full record

ReviewInternational journal of molecular sciences2025

Melatonin/Chitosan Biomaterials for Wound Healing and Beyond: A Multifunctional Therapeutic Approach.

Karolina Kulka-Kamińska, Patrycja Brudzyńska, Mayuko Okura, Tatsuyuki Ishii, Marco Skala, Russel J Reiter, Andrzej T Slominski, Kazuo Kishi, Kerstin Steinbrink, Alina Sionkowska and 1 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Melatonin and the Dental Pulp: A Scoping Review.International endodontic journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karolina Kulka-KamińskaLaboratory for Biomaterials and Cosmetics, Nicolaus Copernicus University in Toruń, Gagarin Str. 7, 87-100 Toruń, Poland.ORCID 0000-0002-0825-1774
Patrycja BrudzyńskaLaboratory for Biomaterials and Cosmetics, Nicolaus Copernicus University in Toruń, Gagarin Str. 7, 87-100 Toruń, Poland.
Mayuko OkuraDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Tatsuyuki IshiiDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Marco SkalaDepartment of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany.ORCID 0009-0008-5720-6487
Russel J ReiterDepartment of Cell Systems and Anatomy, Long School of Medicine, UT Health, San Antonio, TX 78229, USA.ORCID 0000-0001-6763-4225
Andrzej T SlominskiDepartment of Dermatology, Comprehensive Cancer Center, Cancer Chemoprevention Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-8963-3995
Kazuo KishiDepartment of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-4298-9828
Kerstin SteinbrinkDepartment of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany.ORCID 0000-0002-0500-2158
Alina SionkowskaLaboratory for Biomaterials and Cosmetics, Nicolaus Copernicus University in Toruń, Gagarin Str. 7, 87-100 Toruń, Poland.ORCID 0000-0002-1551-2725
Konrad KleszczyńskiDepartment of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany.ORCID 0000-0002-1311-263X

Funding

Mechanism of action and function of novel secosteroid 20(OH)D3 in the skinR01AR073004 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANDRZEJ T SLOMINSKI · 2018 to 2026
$2.9M
BLRD VA I01 BX004293Deutsche Forschungsgemeinschaft, DFG KL2900/3-1Deutsche Forschungsgemeinschaft, DFG TR156/C05-246807620, SFB1009/B11-194468054, SFB1066/B06-213555243, SFB1450/C06-431460824DOD grant W81XWH2210689NIAMS NIH HHS R01 AR073004NIH HHS 1R01AR073004, R01AR071189VA merit 1I01BX004293-01A1
6 · The paper itself

Abstract

Chitosan is increasingly utilized in combination with melatonin in novel formulations for a wide range of therapeutic applications. As a biocompatible and biodegradable polymer, chitosan exhibits notable properties, including antioxidant, antimicrobial, moisturizing, and absorption capabilities, in addition to a high potential for chemical modification due to its functional groups. These characteristics make it a valuable material in biomedical, pharmaceutical, cosmetic, food packaging, and environmental applications. Melatonin, an indoleamine primarily synthesized in the pineal gland but also found in various peripheral organs and in diverse organisms-including plants, bacteria, and fungi-has been extensively investigated for its antioxidant, anti-apoptotic, and anti-inflammatory activities, as well as its roles in immunomodulation, mitochondrial function, and melanin biosynthesis. This review summarizes recent advances in the combined use of chitosan and melatonin, with emphasis on their synergistic effects in wound healing, anti-cancer therapies, tissue engineering (i.e., skin and bone regeneration), and drug delivery systems. Additional potential applications are discussed in the context of cosmetology, aesthetic medicine, and veterinary practice.

Indexed as

Biocompatible MaterialsChitosanMelatoninWound HealingAnimalsAntioxidantsDrug Delivery SystemsHumansTissue EngineeringAntioxidantsBiocompatible MaterialsChitosanMelatoninanti-cancer therapybiomaterialschitosandrug delivery systemsmelatoninwound healing

Identifiers

PMID40649698
PMCPMC12250209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.